CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in participants with relapsed/refractory (R/R) peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), follicular helper T-cell lymphomas...
Phase 3
San Francisco, California, United States and 26 other locations
This research is being done to see if epcoritamab is effective in treating follicular lymphoma as a second line of treatment.The name of the...
Phase 2
Stanford, California, United States and 2 other locations
of TLN-121 as a single agent and in combination with other anti-lymphoma therapies in patients with relapsed or refractory Non-Hodgkin Lymphomas...
Phase 1
Palo Alto, California, United States and 11 other locations
This is a phase II study using risk and response-adapted therapy for low, intermediate and high risk classical Hodgkin lymphoma. Chemotherap...
Phase 2
Palo Alto, California, United States and 7 other locations
primary purpose of this study is to evaluate the anti-tumor activity of TLN-254 monotherapy in participants with relapsed or refractory T-cell lymphoma...
Phase 1
Stanford, California, United States and 4 other locations
in patients with relapsed central nervous system (CNS) lymphoma. This is the first study to examine a naked anti-CD19 monoclonal antibody in...
Phase 1, Phase 2
San Francisco, California, United States
This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...
Phase 2
San Francisco, California, United States and 59 other locations
with acute lymphoblastic leukemia (ALL) and acute lymphoblastic lymphoma (LLy).Primary Therapeutic Objectives:* To improve the event-free su...
Phase 2, Phase 3
Palo Alto, California, United States and 7 other locations
to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...
Phase 2
San Francisco, California, United States and 56 other locations
RADAR is a multicentre, international, randomised, open-label phase III clinical trial composed of 2 trials running in parallel. Trial 1 will be led...
Phase 3
Stanford, California, United States and 69 other locations
Clinical trials
Research sites
Resources
Legal